Brødkrumme Forside DBV Technologies DBV Technologies Develops patches for desensitization of food allergy using epicutaneous delivery. The lead program is in late stage clinical trials for peanut allergy desensitization. DBV Technologies' website Lundbeckfonden BioCapital Investeringsår 2010 IPO in 2013 – DBV (Euronext Paris) Lokation Bagneux, Ill-de-France, France